Reardon DA, Kim TM, Frenel JS, Simonelli M, et al. Treatment with pembrolizumab in programmed death ligand 1-positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE-028 trial. Cancer 2021 Jan 26. doi: 10.1002/cncr.33378.
PMID: 33496357